| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Echelard Yann is a Director at TG THERAPEUTICS, INC.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $9.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | TGTX Tg Therapeutics, Inc. | Director | Sell | 5,000 | $32.57 | $162,850.00 | -2.2% | -4.6% | - | |
| Jun 13, 2025 | TGTX Tg Therapeutics, Inc. | Director | Sell | 10,000 | $36.94 | $369,400.00 | -4.2% | -9.9% | - | |
| Nov 5, 2024 | TGTX Tg Therapeutics, Inc. | Director | Sell | 20,000 | $24.48 | $489,600.00 | -8.2% | +21.7% | +31.6% | |
| Jan 6, 2023 | TGTX Tg Therapeutics, Inc. | Director | Buy | 9,000 | $10.64 | $95,760.00 | +4.7% | +43.3% | +81.9% | |
| Dec 10, 2020 | TGTX Tg Therapeutics, Inc. | Director | Sell | 30,000 | $40.05 | $1,201,500.00 | -18.9% | - | - |